Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis

BACKGROUND & AIMS: Different liver dysfunction biomarkers are used to assess the bleeding risk of patients with cirrhosis, either as such or included in bleeding risk assessment scores. Since the current model of coagulation in patients with cirrhosis describes a procoagulant tendency with incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zermatten, Maxime G., Fraga, Montserrat, Calderara, Debora Bertaggia, Aliotta, Alessandro, Moradpour, Darius, Alberio, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369360/
https://www.ncbi.nlm.nih.gov/pubmed/32715285
http://dx.doi.org/10.1016/j.jhepr.2020.100120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369360/
https://www.ncbi.nlm.nih.gov/pubmed/32715285
http://dx.doi.org/10.1016/j.jhepr.2020.100120

Ejemplares similares